Margaret (Meg) joins Evidera with over 30 years’ experience as an epidemiologist and health services researcher in both the private and public sectors. Private sector experience includes working at several contract research organizations (PPD Inc, ICON plc, and PRA Health Sciences) as well as several sponsors (AbbVie, TAP Pharmaceutical Products, and Sanofi/Genzyme). In the private sector and immediately prior to working at Evidera, Meg served as an executive director of scientific affairs at PRA Health Sciences in their real world solutions business unit. Prior to PRA, she served as vice president of data analytics and epidemiology/real world strategy and analytics at Mapi Group (now ICON plc). Prior to ICON, Meg served nearly seven years as an executive director of epidemiology/real-world outcomes at PPD Inc. Before joining PPD, she served as director, global patient safety and risk management at the Genzyme Corporation. At both Genzyme (now a Sanofi company) and Abbott Labs (now AbbVie), she managed the quarterly data mining and ‘signal’ (safety issue) detection and evaluation programs for each company’s post-marketed product line.
Meg’s public sector service includes 10 years with the Rhode Island Department of Health, the Illinois Department of Public Health, and Quality Partners of Rhode Island (a Centers for Medicare and Medicaid Services quality improvement contractor).
Meg received her BS in nutrition from the University of New Hampshire and her MPH and PhD from the University of Illinois at Chicago’s School of Public Health, after which she served a two-year tour of duty with the US Public Health Service as a member of the Centers for Disease Control and Prevention’s Epidemic Intelligence Service.
Meg has managed every stage of a real-world study including design, data collection, analysis, reporting, and publication. She is also a skilled SAS programmer and is certified in focus group conduct.